Company: ARAI
Filing Date: 2025-06-17
Form Type: S-1
Source: 0001641172-25-015428
Chunk: 82

Company: Arrive AI Inc.
Filing Date: 2025-06-17
Form: S-1
Chunk 82
---
 available for public disclosure. However,
they define the nature of the customer’s operations, specify the work to be performed by both parties (SOW), and outline where
our services will be used. They also detail the services Arrive AI must provide and establish initial pricing. All terms are subject
to change as both parties gain insight into the actual economics, benefits, and sustainability of this initial engagement. We anticipate
renegotiation in 2026, and the customer may cancel the existing or any renegotiated agreement at any time.

Our 2025 prospect pipeline includes assisted
living communities and hospital chains that have expressed interest in implementing AP3 to support courier, drone, and robotic delivery
systems. Arrive AI does not know if any of the assisted living communities and hospital chains that expressed interest will enter into
agreements with us for our services.

These opportunities are pending contracts and
subject to demonstration pilots, analysis, and drone regulatory approval, with initial phases expected to complete in 2025. If drone
regulatory approval is delayed, implementations can proceed at a modified pace using courier and robotic delivery systems while awaiting
FAA approval.

| 34 |

AP development progression and roadmap

| ○ | AP1 and AP2: Initial mailboxes / Access Points utilized                                                                                  
 for customer learning and pilot programs, including successful pilot in Lawrence, Indiana in 2022 with the USPS and local DoorDash       
 and Uber Eats operations.                                                                                                                |
| ○ | AP3: has completed manufacturing and design enhancements and                                                                             
 was deployed in December of 2024 with an East Coast Specialty Pharma logistics company under a signed SOW. Production support of         
 their MaaS is scheduled for 2025. Their MaaS recurring revenue is anticipated to begin in the first half of 2025. Customer VAR (Value    
 Added Resales) by this same company is also planned to begin in first half of 2025 which will increase Arrive AI MaaS recurring revenue  
 in the second half of 2025. The terms of this agreement are confidential and not available for public disclosure. However, they define   
 the nature of the customer’s pilot operations, specify the pilot work to be performed by both parties (SOW), and outline where           
 our services will be used. They also detail the services Arrive AI must provide and establish initial pricing. All terms are subject     
 to change as both parties gain insight into the actual economics, benefits, and sustainability of this initial engagement. We anticipate 
 renegotiation in 202